---
title: "12 Health Care Stocks Moving In Tuesday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305048396.md"
description: "On Tuesday, healthcare stocks showed significant intraday volatility. Gainers included PepGen (up 126.6%), Nano X Imaging (+35.31%), and Longeveron (+30.34%). Conversely, major losers were Karyopharm Therapeutics (-42.5%), Tessera Defense (-37.44%), and Exagen (-28.6%). Several companies, including PepGen, Exagen, and P3 Health Partners, released Q3 earnings reports around this period."
datetime: "2026-11-10T17:05:38.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305048396.md)
  - [en](https://longbridge.com/en/news/305048396.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305048396.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Tuesday's Intraday Session

### Gainers

-   **PepGen** (NASDAQ:PEPG) stock rose 126.6% to $5.42 during Tuesday's regular session. The company's market cap stands at $165.5 million. The company's, Q3 earnings came out today.
-   **Nano X Imaging** (NASDAQ:NNOX) stock increased by 35.31% to $0.32. The company's market cap stands at $18.3 million.
-   **Longeveron** (NASDAQ:LGVN) stock increased by 30.34% to $2.62. The market value of their outstanding shares is at $6.4 million.
-   **Estrella Immunopharma** (NASDAQ:ESLA) shares rose 25.25% to $0.64. The company's market cap stands at $22.3 million.
-   **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock moved upwards by 24.31% to $0.18.
-   **Humacyte** (NASDAQ:HUMA) stock rose 21.94% to $0.56. The market value of their outstanding shares is at $126.4 million. As per the news, the Q3 earnings report came out today.

### Losers

-   **Karyopharm Therapeutics** (NASDAQ:KPTI) shares decreased by 42.5% to $0.02 during Tuesday's regular session.
-   **Tessera Defense** (AMEX:HLSQ) stock fell 37.44% to $0.07. The market value of their outstanding shares is at $2.3 million.
-   **Exagen** (NASDAQ:XGN) shares decreased by 28.6% to $5.07. The company's market cap stands at $171.5 million. The company's, Q3 earnings came out today.
-   **Cosmos Health** (NASDAQ:COSM) stock declined by 26.59% to $0.2. The company's market cap stands at $26.9 million.
-   **P3 Health Partners** (NASDAQ:PIII) stock fell 24.95% to $3.19. The market value of their outstanding shares is at $16.6 million. The company's, Q3 earnings came out yesterday.
-   **Coherus Oncology** (NASDAQ:CHRS) stock declined by 22.44% to $0.63. The market value of their outstanding shares is at $126.3 million. As per the news, the Q3 earnings report came out yesterday. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [KPTI.US](https://longbridge.com/en/quote/KPTI.US.md)
- [LGVN.US](https://longbridge.com/en/quote/LGVN.US.md)
- [NNOX.US](https://longbridge.com/en/quote/NNOX.US.md)
- [PEPG.US](https://longbridge.com/en/quote/PEPG.US.md)
- [XGN.US](https://longbridge.com/en/quote/XGN.US.md)
- [KPTIQ.US](https://longbridge.com/en/quote/KPTIQ.US.md)
- [CHRS.US](https://longbridge.com/en/quote/CHRS.US.md)
- [COSM.US](https://longbridge.com/en/quote/COSM.US.md)
- [ESLA.US](https://longbridge.com/en/quote/ESLA.US.md)
- [HLSQ.US](https://longbridge.com/en/quote/HLSQ.US.md)
- [HUMA.US](https://longbridge.com/en/quote/HUMA.US.md)
- [PIII.US](https://longbridge.com/en/quote/PIII.US.md)

## Related News & Research

- [BUZZ-PepGen surges as co seeks equity raise following muscle disease drug data](https://longbridge.com/en/news/305192269.md)
- [Diagnostics firm Exagen's Q3 revenue slightly beats estimates on higher test volumes, prices](https://longbridge.com/en/news/305012416.md)
- [PepGen Launches $125 Million Public Stock Offering](https://longbridge.com/en/news/305070350.md)
- [Biotech firm PepGen's Q3 net loss widens as R&D expenses rise](https://longbridge.com/en/news/305009017.md)
- [PepGen Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights | PEPG Stock News](https://longbridge.com/en/news/305009104.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**